These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 1978857)

  • 1. Human immunodeficiency virus and the primary care physician.
    Paauw DS; O'Neill JF
    J Fam Pract; 1990 Dec; 31(6):646-50. PubMed ID: 1978857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing HIV infection in office practice. Assessing risk, counseling, and testing.
    Kassler WJ; Wu AW
    Prim Care; 1992 Mar; 19(1):19-33. PubMed ID: 1594696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' ability to provide initial primary care to an HIV-infected patient.
    Curtis JR; Paauw DS; Wenrich MD; Carline JD; Ramsey PG
    Arch Intern Med; 1995 Aug 7-21; 155(15):1613-8. PubMed ID: 7618984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient management of patients infected with human immunodeficiency virus.
    Bender BS
    J Fam Pract; 1992 Apr; 34(4):464-7, 471-4, 477-82. PubMed ID: 1348266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive care among HIV-positive patients in a general medicine practice.
    Gifford AL; McPhee SJ; Fordham D
    Am J Prev Med; 1994; 10(1):5-9. PubMed ID: 7909673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting the challenge of early identification of HIV infection in primary care.
    Vergeront JM; Reiser WJ; Krchnavek KA; Druckenmiller JK; Davis JP
    WMJ; 1998 Dec; 97(11):52-61. PubMed ID: 9894442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine improves psoriasis in human immunodeficiency virus-positive males.
    Duvic M; Crane MM; Conant M; Mahoney SE; Reveille JD; Lehrman SN
    Arch Dermatol; 1994 Apr; 130(4):447-51. PubMed ID: 7909423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of human immunodeficiency virus testing and posttest counseling among outpatients with serious mental illness.
    Desai MM; Rosenheck RA; Desai RA
    J Nerv Ment Dis; 2007 Sep; 195(9):776-80. PubMed ID: 17984780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV testing: issues for the family physician.
    Kaminski MA; Hartmann PM
    Am Fam Physician; 1988 Jul; 38(1):117-22. PubMed ID: 3394598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
    Ibáñez A; Peraire J; Arnó A; Gutiérrez C; Cervantes M; Colomer J; Villalonga C; Camafort M; Ruiz L; Balaguer M; Vidal F; Richart C; Clotet B
    Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and activity of zalcitabine and zidovudine combination in HIV-positive people with CD4 cell counts < or = 300 cells/mm3. The Roche M50002 Study Group.
    Moyle GJ; Walker M; Harris R; Kellagher A; Warburg M
    Antivir Ther; 1996 Aug; 1(3):180-8. PubMed ID: 11322252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical management of the HIV-infected patient.
    Powderly WG
    Mo Med; 1989 Oct; 86(10):685-7. PubMed ID: 2571922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for notification of seropositivity: ethical and psychological aspects].
    De Wit S; Flausch A
    Rev Med Brux; 1996 Sep; 17(4):167-70. PubMed ID: 8927839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Counseling and HIV-testing among hospital patients in Arusha and Kilimanjaro].
    Lie GT; Biswalo PM; Klepp KI
    Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3286-8. PubMed ID: 7482463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV counseling, testing, and prevention in primary care.
    Kosko DA; Becker KL
    Lippincotts Prim Care Pract; 2000; 4(1):29-39; quiz 40-2. PubMed ID: 11022518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive counseling, screening, and therapy for the patient with newly diagnosed HIV infection.
    Khalsa AM
    Am Fam Physician; 2006 Jan; 73(2):271-80. PubMed ID: 16445273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.